You searched for obesity | Page 9 of 30

Biomarkers Could Point to Preclampsia Risk

Posted by Chris Wolski | Nov 11, 2022 | Prenatal Testing |

Cedars-Sinai investigators have found that a specific imbalance of two placental proteins could predict preeclampsia risk.

The organizations have established an exclusive license agreement to any diagnostic techniques utilizing imprintome control regions.

Molex has released the results of a global survey identifying market drivers impacting the development of diagnostic wearables.

Nonalcoholic steatohepatitis, a type of fatty liver disease that might progress to cancer, is a prevalent health concern among the obese.

Cedars-Sinai Cancer investigators have created a blood test that uses a technology to detect the most common form of liver cancer.